小野薬品工業(株)【4528】の掲示板 2020/03/21〜2020/04/19

ONO 5334 hold near-term promise to fight the novel coronavirus.

(ONO-5334はカテプシンK阻害剤で、骨粗鬆症. を対象として開発を進めています。 ビスホスフォ. ネート製剤と異なり、骨形成に影響を及ぼさず、. 骨吸収のみを抑制する新しい作用メカニズムの. 骨粗鬆症治療剤です)

Sanford Burnham Prebys Medical Discovery Institute
Researchers use live virus to identify 30 existing drugs that could treat COVID-19
April 18, 2020

Four drugs hold near-term promise to fight the novel coronavirus.

Scientists at Sanford Burnham Prebys Medical Discovery Institute, the University of Hong Kong, Scripps Research, UC San Diego School of Medicine, the Icahn School of Medicine at Mount Sinai and UCLA have identified 30 existing drugs that stop the replication of SARS-CoV-2, the virus that causes COVID-19.

Based on the extensive data in this study, we believe the four drugs described above—aplimod, MLN-3897, VBY-825 and ONO 5334—represent the best new approaches for a near-term COVID-19 treatment,” says Chanda.